Press release
Sarcopenia Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Epidemiology, Medication, NDA Approvals, Pipeline, Therapeutics and Companies by DelveInsight
Sarcopenia Drugs Market
(Albany, USA) DelveInsight's "Sarcopenia Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Sarcopenia, historical and forecasted epidemiology as well as the Sarcopenia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Sarcopenia market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Sarcopenia market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Sarcopenia treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Sarcopenia market.
Request for a Free Sample Report @ [https://www.delveinsight.com/report-store/sarcopenia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some of the Key facts of Sarcopenia Market are:
* According to DelveInsight's analysis, sarcopenia market size in the 7MM is expected to grow at a significant CAGR by 2034.
* The total diagnosed prevalent cases of sarcopenia in the 7MM was 27.4 million cases in 2023 and this number is forecasted to climb at a significant CAGR in the research period (2020-2034).
* The Sarcopenia market size in the 7MM reached approximately USD 2,731 million in 2022. Projections indicate a substantial growth during the forecast period.
* Amongst the EU-5 countries, Italy had the highest number of cases followed by Germany with 3,556,282 and 3,194,532 cases respectively. Spain accounted for least number of sarcopenia cases in 2021.
* Japan accounted for 3,104,585 cases sarcopenia in 2021, which accounted for approximately 9% of the total 7MM prevalent cases of sarcopenia.
* According to DelveInsight, males are affected more as compared to females in case of sarcopenia.
* Leading Sarcopenia companies working in the market are MyMD Pharmaceuticals, Biophytis, Dystrogen Therapeutics, Rejuvenate Biomed, Oncocross Therapeutics, OPKO health, NMD Pharma, Rubedo Life Sciences, Immunoforge, and others.
* Sarcopenia therapies expected to launch are Sarconeos (BIO101), MYMD-1, and others.
* In August 2024, TNF Pharmaceuticals, Inc. announced plans to move forward with its lead program, MYMD-1, into fully funded mid-stage clinical trials. The upcoming studies will further investigate the drug's effectiveness in treating sarcopenia/frailty, following statistically significant positive outcomes from a previous Phase II trial.
Sarcopenia Overview
Sarcopenia is a progressive and generalized skeletal muscle disorder characterized by the loss of muscle mass, strength, and function. It primarily affects older adults, contributing significantly to frailty, disability, and reduced quality of life. Sarcopenia can also be associated with chronic diseases, malnutrition, and a sedentary lifestyle.
The onset of sarcopenia is influenced by a combination of age-related changes in muscle tissue, hormonal shifts, inflammation, and decreased physical activity. Muscle fibers shrink and are lost, leading to decreased muscle mass and strength. Additionally, there is often a reduction in the body's ability to synthesize muscle proteins, further exacerbating muscle loss.
Diagnosis of sarcopenia typically involves assessing muscle mass, strength, and physical performance. Tools like dual-energy X-ray absorptiometry (DEXA) scans, grip strength measurements, and gait speed tests are commonly used.
Managing sarcopenia involves a multifaceted approach, including resistance and aerobic exercise to improve muscle strength and function, nutritional interventions such as increased protein intake, and addressing underlying health conditions. In some cases, pharmacological treatments may be considered.
Early identification and intervention are crucial in mitigating the impacts of sarcopenia, helping to maintain independence and improve the overall quality of life in affected individuals. Ongoing research aims to better understand the mechanisms of sarcopenia and develop more effective treatments.
Learn more about Sarcopenia treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @ [https://www.delveinsight.com/sample-request/sarcopenia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Sarcopenia Market
The Sarcopenia market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Sarcopenia market trends by analyzing the impact of current Sarcopenia therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.
This segment gives a thorough detail of the Sarcopenia market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Sarcopenia market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Sarcopenia market in 7MM is expected to witness a major change in the study period 2020-2034.
Sarcopenia Epidemiology
The Sarcopenia epidemiology section provides insights into the historical and current Sarcopenia patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Sarcopenia market report also provides the diagnosed patient pool, trends, and assumptions.
Explore more about Sarcopenia Epidemiology @ [https://www.delveinsight.com/sample-request/sarcopenia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Sarcopenia Drugs Uptake
This section focuses on the uptake rate of the potential Sarcopenia drugs recently launched in the Sarcopenia market or expected to be launched in 2020-2034. The analysis covers the Sarcopenia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Sarcopenia Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Sarcopenia market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Some of the Sarcopenia companies and therapies:
* Biophytis: Sarconeos (BIO101)
* Rejuvenate Biomed: RJx-01
* Lipocine Inc: LPCN 1148
* And Many Others
Sarcopenia Pipeline Development Activities
The Sarcopenia report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Sarcopenia key players involved in developing targeted therapeutics.
Request for a sample report to understand more about the Sarcopenia pipeline development activities @ [https://www.delveinsight.com/sample-request/sarcopenia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Sarcopenia Therapeutics Assessment
Major key companies are working proactively in the Sarcopenia Therapeutics market to develop novel therapies which will drive the Sarcopenia treatment markets in the upcoming years are MyMD Pharmaceuticals, Biophytis, Dystrogen Therapeutics, Rejuvenate Biomed, Oncocross Therapeutics, OPKO health, NMD Pharma, Rubedo Life Sciences, Immunoforge, and others.
Learn more about the emerging Sarcopenia therapies & key companies @ [https://www.delveinsight.com/sample-request/sarcopenia-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Sarcopenia Report Key Insights
1. Sarcopenia Patient Population
2. Sarcopenia Market Size and Trends
3. Key Cross Competition in the Sarcopenia Market
4. Sarcopenia Market Dynamics (Key Drivers and Barriers)
5. Sarcopenia Market Opportunities
6. Sarcopenia Therapeutic Approaches
7. Sarcopenia Pipeline Analysis
8. Sarcopenia Current Treatment Practices/Algorithm
9. Impact of Emerging Therapies on the Sarcopenia Market
Table of Contents
1. Key Insights
2. Executive Summary
3. Sarcopenia Competitive Intelligence Analysis
4. Sarcopenia Market Overview at a Glance
5. Sarcopenia Disease Background and Overview
6. Sarcopenia Patient Journey
7. Sarcopenia Epidemiology and Patient Population
8. Sarcopenia Treatment Algorithm, Current Treatment, and Medical Practices
9. Sarcopenia Unmet Needs
10. Key Endpoints of Sarcopenia Treatment
11. Sarcopenia Marketed Products
12. Sarcopenia Emerging Therapies
13. Sarcopenia Seven Major Market Analysis
14. Attribute Analysis
15. Sarcopenia Market Outlook (7 major markets)
16. Sarcopenia Access and Reimbursement Overview
17. KOL Views on the Sarcopenia Market
18. Sarcopenia Market Drivers
19. Sarcopenia Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=sarcopenia-drugs-market-2034-ema-pdma-fda-approvals-clinical-trials-epidemiology-medication-nda-approvals-pipeline-therapeutics-and-companies-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/aacr-annual-meeting
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sarcopenia Drugs Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Epidemiology, Medication, NDA Approvals, Pipeline, Therapeutics and Companies by DelveInsight here
News-ID: 3872535 • Views: …
More Releases from ABNewswire
Bedrock Plumbing & Drain Cleaning Brings Home Top Award for Plumbers in Fulton, …
This accolade is more than a local triumph; it signals the company's expanding reputation for technical mastery, rapid response, and ethical service delivery across Southwest Minneapolis, including key areas like Edina and the surrounding suburbs.
In the competitive service industry of the Twin Cities metro area, achieving recognition for superior quality and reliability is a significant accomplishment. Bedrock Plumbing & Drain Cleaning has recently secured a prestigious top award for plumbers…
Certified Excellence: Mountain Roofers Receives Random Roof Inspection Citation, …
For homeowners, this independent recognition provides exceptional assurance that they are partnering with a roof inspection company that not only meets but exceeds the stringent industry requirements necessary for durable, code-compliant roofing systems.
In the rapidly growing community of Lehi, Utah, where construction and quality assurance are paramount, Mountain Roofers has achieved a significant and rare distinction. The company recently received a formal citation for excellence following a random, unannounced local…
American Fork, UT Community Favorite: Mountain Roofers Named Winner of the 'Neig …
The honor highlights a business model built on professionalism and a deep commitment to the local community, setting a high benchmark for quality workmanship and customer care within the highly competitive construction industry.
The community of American Fork, Utah, has spoken, and the consensus is clear: Mountain Roofers stands out as the premier provider in the roofing sector. This year, the company was honored with the coveted "Neighbor's Choice Local Roof…
Limmat-Zurich Umzug GmbH Strengthens Its Position as the Trusted Umzugsfirma Zur …
Umzugsfirma Zurich, Limmat-Zurich Umzug GmbH is a moving company for expats that now offers transport, storage, waste removal, and handover cleaning.
Image: https://www.abnewswire.com/upload/2025/11/0aab7b1f279c8ff971ed4b490575bc74.jpg
Limmat-Zurich Umzug GmbH, widely known as a trusted Umzugsfirma Zurich [https://limmat-zuerich-umzug.ch/en/] or in other words, a reliable moving company in Zurich, has emerged as the preferred moving company for English-speaking expatriates relocating within the Greater Zurich Area. With hundreds of positive Google Reviews, the company continues to meet the…
More Releases for Sarcopenia
Key Factor Supporting Global Sarcopenia Treatment Market Development in 2025: Su …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Sarcopenia Treatment Market Size By 2025?
The market dedicated to sarcopenia treatments has witnessed robust expansion over the past few years, projected to escalate from a valuation of $3.52 billion in 2024 to $3.72 billion a year later, reflecting a compound annual growth rate of…
Sarcopenia Market Size, Share & Growth Analysis 2034
Sarcopenia Market Overview
Sarcopenia is a condition characterized by the progressive loss of muscle mass, strength, and function, primarily affecting the elderly. This decline leads to increased frailty, higher risk of falls, and diminished quality of life. The rising global geriatric population has heightened the prevalence of sarcopenia, making it a significant public health concern. Consequently, there is a growing demand for effective treatments and interventions to manage and mitigate the…
Sarcopenia Treatment Market Report 2024 - Sarcopenia Treatment Market Size And G …
"The Business Research Company recently released a comprehensive report on the Global Sarcopenia Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The sarcopenia treatment market…
Sarcopenia Pipeline Insights Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Sarcopenia Pipeline constitutes 8+ key companies continuously working towards developing 10+ Sarcopenia Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Sarcopenia Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Sarcopenia NDA approvals (if any), and product…
Global Sarcopenia Therapeutic Market Research Report 2023
The global Sarcopenia Therapeutic market was valued at US$ 2867.6 million in 2022 and is anticipated to reach US$ 3484.4 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029.
view full report
https://reports.valuates.com/market-reports/QYRE-Auto-13K14453/global-sarcopenia-therapeutic
Sarcopenia Therapeutic Market
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China is the largest consumption region of…
Sarcopenia - Drug Pipeline Landscape, 2022
Sarcopenia is a condition characterized by the loss of muscle mass and strength. It can occur due to a variety of reasons, including aging, inactivity, and certain chronic diseases.
Aging is the most common cause of sarcopenia. As people age, they tend to become less active and lose muscle mass. This process is known as age-related muscle loss or sarcopenia with aging.
Inactivity can also lead to sarcopenia. People who are not…
